Clinical trial
Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study
NCT04884971 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study
- Lead sponsor
- University of Minnesota
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 3, 2021
- Completion date
- December 31, 2023
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.